BR0008916B1 - Composição enteral nutricional projetada para favorecer o crescimento e a maturação de tratos gastrointestinais não maduros de mamíferos jovens e seu uso - Google Patents
Composição enteral nutricional projetada para favorecer o crescimento e a maturação de tratos gastrointestinais não maduros de mamíferos jovens e seu usoInfo
- Publication number
- BR0008916B1 BR0008916B1 BRPI0008916-8B1A BR0008916A BR0008916B1 BR 0008916 B1 BR0008916 B1 BR 0008916B1 BR 0008916 A BR0008916 A BR 0008916A BR 0008916 B1 BR0008916 B1 BR 0008916B1
- Authority
- BR
- Brazil
- Prior art keywords
- maturation
- favor
- growth
- gastrointestinal tract
- composition designed
- Prior art date
Links
- 210000001035 gastrointestinal tract Anatomy 0.000 title 1
- 230000035800 maturation Effects 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99200753A EP1034704A1 (en) | 1999-03-12 | 1999-03-12 | Nutritional composition intended for specific gastro-intestinal maturation in premature mammals |
| PCT/EP2000/001744 WO2000054603A1 (en) | 1999-03-12 | 2000-03-01 | Nutritional composition intended for specific gastro-intestinal maturation in premature mammals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR0008916A BR0008916A (pt) | 2002-01-15 |
| BR0008916B1 true BR0008916B1 (pt) | 2013-12-03 |
Family
ID=8239977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0008916-8B1A BR0008916B1 (pt) | 1999-03-12 | 2000-03-01 | Composição enteral nutricional projetada para favorecer o crescimento e a maturação de tratos gastrointestinais não maduros de mamíferos jovens e seu uso |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6733770B1 (enExample) |
| EP (2) | EP1034704A1 (enExample) |
| JP (1) | JP2002538797A (enExample) |
| CN (1) | CN1200613C (enExample) |
| AP (1) | AP1381A (enExample) |
| AT (1) | ATE279123T1 (enExample) |
| AU (1) | AU766518B2 (enExample) |
| BR (1) | BR0008916B1 (enExample) |
| CA (1) | CA2364031A1 (enExample) |
| CZ (1) | CZ20013288A3 (enExample) |
| DE (1) | DE60014868T3 (enExample) |
| DK (1) | DK1161152T4 (enExample) |
| ES (1) | ES2228490T5 (enExample) |
| HU (1) | HUP0200292A2 (enExample) |
| IL (1) | IL144814A0 (enExample) |
| NO (1) | NO322739B1 (enExample) |
| NZ (1) | NZ513918A (enExample) |
| OA (1) | OA11844A (enExample) |
| PL (1) | PL196104B1 (enExample) |
| PT (1) | PT1161152E (enExample) |
| RU (1) | RU2225140C2 (enExample) |
| SK (1) | SK12822001A3 (enExample) |
| TR (1) | TR200102601T2 (enExample) |
| UA (1) | UA72915C2 (enExample) |
| WO (1) | WO2000054603A1 (enExample) |
| ZA (1) | ZA200106744B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0204439A3 (en) * | 2000-02-04 | 2004-12-28 | Nestle Sa | A method for maintaining or improving the synthesis of mucins |
| EP1281325A1 (en) * | 2001-07-30 | 2003-02-05 | Societe Des Produits Nestle S.A. | Nutritional composition preventing bacterial overgrowth |
| CA2489942A1 (en) | 2002-07-01 | 2004-01-08 | Unilever Plc | Satiety inducing composition |
| TWI317636B (en) * | 2002-11-22 | 2009-12-01 | Meiji Dairies Corp | Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress |
| JP5068174B2 (ja) | 2004-12-23 | 2012-11-07 | カンピナ ネーデルランド ホールディング ビー.ブイ. | Dpp−ivを阻害するペプチド中に濃縮されたタンパク質の加水分解物及びその使用 |
| US20060286208A1 (en) * | 2005-06-01 | 2006-12-21 | Nagendra Rangavajla | Methods for producing protein partial hydrolysates and infant formulas containing the same |
| US7618669B2 (en) * | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| US7572474B2 (en) | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
| US8075934B2 (en) * | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
| JP2009517464A (ja) | 2005-11-30 | 2009-04-30 | カンピーナ ネーダーランド ホールディング ビー.ブイ. | グルカゴン様ペプチド1の活性を増強するタンパク質加水分解物の使用 |
| EP2046362B1 (en) * | 2006-06-15 | 2013-03-27 | Murray Goulburn CO-Operative CO. Limited | Formulation comprising whey protein and hydrolysates for improving muscle recovery |
| EP1911457A1 (en) | 2006-10-12 | 2008-04-16 | N.V. Nutricia | Composition to treat or prevent gastrointestinal infection |
| EP2044851A1 (en) * | 2007-09-26 | 2009-04-08 | Nestec S.A. | Prevention of allergy at weaning |
| WO2009047754A2 (en) | 2007-10-09 | 2009-04-16 | Enzymotec Ltd. | Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation |
| BRPI0821244A2 (pt) * | 2007-12-14 | 2014-12-23 | Nestec Sa | Proteína de cereal hipoalergênica e seus usos |
| US8377496B2 (en) * | 2007-12-20 | 2013-02-19 | Abbott Laboratories | Stable nutritional powder |
| US8361534B2 (en) * | 2007-12-20 | 2013-01-29 | Abbott Laboratories | Stable nutritional powder |
| CA2805888C (en) | 2008-10-17 | 2016-08-16 | Nestec S.A. | Whey protein compostions, methods and uses |
| US8367354B2 (en) | 2008-10-24 | 2013-02-05 | Mead Johnson Nutrition Company | Methods for determining the levels of TGF-β in a composition |
| US8350006B2 (en) | 2008-10-24 | 2013-01-08 | Mead Johnson Nutrition Company | Methods for determining the bioactivity of TGF-β in a composition |
| US8986769B2 (en) * | 2008-10-24 | 2015-03-24 | Mead Johnson Nutrition Company | Methods for preserving endogenous TGF-β |
| WO2011122937A1 (en) * | 2010-03-29 | 2011-10-06 | N.V. Nutricia | Pea protein peptides with anti helicobacter pylori activity |
| WO2011148221A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Lactic acid bacteria for maturation of the enteric nervous system in infants |
| US20120171328A1 (en) | 2011-01-05 | 2012-07-05 | Dattatreya Banavara | Composition comprising heat labile milk proteins and process for preparing same |
| EP2508193A1 (en) * | 2011-04-05 | 2012-10-10 | Nestec S.A. | Use of a hypoallergenic cereal composition for inducing specific oral tolerance |
| HK1202782A1 (en) * | 2011-12-30 | 2015-10-09 | Abbott Laboratories | Stabilized concentrated liquid human milk fortifier |
| CN108430490A (zh) * | 2015-12-03 | 2018-08-21 | 株式会社明治 | 营养组合物 |
| WO2018221526A1 (ja) * | 2017-06-01 | 2018-12-06 | 株式会社明治 | 栄養組成物 |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4977137B1 (en) * | 1987-06-03 | 1994-06-28 | Baylor College Medicine | Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract |
| EP0322589B1 (fr) * | 1987-12-23 | 1993-01-20 | Societe Des Produits Nestle S.A. | Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques |
| ES2063882T5 (es) * | 1989-10-02 | 2001-12-01 | Novartis Nutrition Ag | Hidrolizados de proteinas. |
| US5183805A (en) * | 1990-08-13 | 1993-02-02 | Board Of Regents, The University Of Texas System | Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| US5514655A (en) * | 1993-05-28 | 1996-05-07 | Abbott Laboratories | Enteral nutritional with protein system containing soy protein hydrolysate and intact protein |
| US5405637A (en) * | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
| CA2163379A1 (en) * | 1994-11-23 | 1996-05-24 | Douglas E. Hahn | Nutritional composition containing improved dietary nitrogen component |
| PT827697E (pt) * | 1996-09-06 | 2002-11-29 | Nestle Sa | Inducao da tolerancia ao leite de vaca |
| CA2223198A1 (en) * | 1997-01-14 | 1998-07-14 | Societe Des Produits Nestle S.A. | Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
| EP0852913A1 (en) * | 1997-01-14 | 1998-07-15 | Societe Des Produits Nestle S.A. | Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
-
1999
- 1999-03-12 EP EP99200753A patent/EP1034704A1/en not_active Withdrawn
-
2000
- 2000-03-01 UA UA2001106792A patent/UA72915C2/uk unknown
- 2000-03-01 CZ CZ20013288A patent/CZ20013288A3/cs unknown
- 2000-03-01 CA CA002364031A patent/CA2364031A1/en not_active Abandoned
- 2000-03-01 CN CNB008046581A patent/CN1200613C/zh not_active Expired - Fee Related
- 2000-03-01 RU RU2001127667/13A patent/RU2225140C2/ru not_active IP Right Cessation
- 2000-03-01 HU HU0200292A patent/HUP0200292A2/hu unknown
- 2000-03-01 PT PT00916886T patent/PT1161152E/pt unknown
- 2000-03-01 BR BRPI0008916-8B1A patent/BR0008916B1/pt not_active IP Right Cessation
- 2000-03-01 US US09/936,446 patent/US6733770B1/en not_active Expired - Lifetime
- 2000-03-01 AT AT00916886T patent/ATE279123T1/de active
- 2000-03-01 AU AU38077/00A patent/AU766518B2/en not_active Ceased
- 2000-03-01 DE DE60014868T patent/DE60014868T3/de not_active Expired - Lifetime
- 2000-03-01 NZ NZ513918A patent/NZ513918A/en not_active IP Right Cessation
- 2000-03-01 WO PCT/EP2000/001744 patent/WO2000054603A1/en not_active Ceased
- 2000-03-01 JP JP2000604696A patent/JP2002538797A/ja active Pending
- 2000-03-01 ES ES00916886T patent/ES2228490T5/es not_active Expired - Lifetime
- 2000-03-01 OA OA1200100229A patent/OA11844A/en unknown
- 2000-03-01 AP APAP/P/2001/002244A patent/AP1381A/en active
- 2000-03-01 DK DK00916886.5T patent/DK1161152T4/da active
- 2000-03-01 EP EP00916886A patent/EP1161152B2/en not_active Expired - Lifetime
- 2000-03-01 IL IL14481400A patent/IL144814A0/xx not_active IP Right Cessation
- 2000-03-01 TR TR2001/02601T patent/TR200102601T2/xx unknown
- 2000-03-01 SK SK1282-2001A patent/SK12822001A3/sk unknown
- 2000-03-01 PL PL350227A patent/PL196104B1/pl unknown
-
2001
- 2001-08-15 ZA ZA200106744A patent/ZA200106744B/en unknown
- 2001-09-04 NO NO20014297A patent/NO322739B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0008916B1 (pt) | Composição enteral nutricional projetada para favorecer o crescimento e a maturação de tratos gastrointestinais não maduros de mamíferos jovens e seu uso | |
| DK1102549T3 (da) | Ernæringsmæssig fuldstændig enteral formulering med lav pH | |
| FI940629A7 (fi) | Valmiste ruoansulatuskanavan sisäiseen ravitsemukseen | |
| ATE464797T1 (de) | Säuglingsnährpräparat mit verbesserter fettzusammensetzung | |
| EE05450B1 (et) | 4-jodofenlaminobenshdroksaamhapete oksgeenitud estrid, nende kristallvormid ja farmatseutilised kompositsioonid ning kasutamine | |
| IS6205A (is) | Lyfja- og næringarsamsetningar sem innihalda nauðsynlegar fitusýrur og hómósystein-lækkandi miðla | |
| MA23533A1 (fr) | Formes posologiques d'azithromycine | |
| AU2001256856A1 (en) | Nutritional preparation comprising ribose and folic acid and medical use thereof | |
| EE200100413A (et) | Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks | |
| DE69904208D1 (de) | Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure | |
| NO20030827D0 (no) | Antistoffer mot human IL-1<beta> | |
| EE05067B1 (et) | Aminoproplfosfiinhapped ning nende kasutamine meditsiinis | |
| NO20023266L (no) | Antistoffer mot humant IL-1<beta> | |
| EE200200012A (et) | Suukaudselt manustatav maskeeritud maitsega vedelpreparaat | |
| DE69310443D1 (de) | Präparat zur oralen Hygiene | |
| DE69940656D1 (de) | Wegwerfwindel mit mechanischen Befestigungsmitteln | |
| AR019261A1 (es) | Cetoazalido de la clase de lactamas de 15 miembros, su uso, procedimiento para prepararlo , y una composicion farmaceutica util para el tratamiento de infecciones bacterianas en seres humanos y animales | |
| DE60128647D1 (de) | Sigec halbleiterkristall und seine herstellung | |
| EE200200271A (et) | Ravimkombinatsioonid ning nende kasutamine | |
| DE69225979D1 (de) | Orale zubereitung zur freisetzung im unteren verdauungstract | |
| ATE534636T1 (de) | Krystalline form ii von ritonavir enthaltende pharmazeutische zusammensetzung und ihre herstellung | |
| PL364171A1 (en) | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | |
| DE60015567D1 (de) | Herbizide zusammensetzungen und anwendungsverfahren | |
| KR940020921A (ko) | 분유와 이유식에 한약을 첨가한 한방분유와 한방이유식의 조제법 | |
| DE60020862D1 (de) | 7-acylamino-3-heteroarylthio-3-cephemcarbonsäure antibiotika und deren vorwirkstoffe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT. CL.: A23J 3/34, A23L 1/305. Ipc: A23J 3/34 (2006.01), A23L 1/305 (2006.01), A61K 38 |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/12/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A23J 3/34 (2006.01), A23L 33/18 (2016.01), A23L 33 |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 19A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2503 DE 26-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |